Search

EX VIVO EVOLUTION OF HUMAN ANTIBODIES BY CRISPR-X: FROM A NAIVE B CELL REPERTOIRE TO AFFINITY MATURED ANTIBODIES

Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M

HALOZYME GETS $30M FROM ARGENX IN LICENSING DEAL WORTH UP TO $530M

Argenx, a Dutch firm with a pipeline of investigational antibody-based therapies, will pay San Diego-based Halozyme to use its drug...

 
 
 
Improved HCP Reduction Using a New, All‐Synthetic Depth Filtration Media Within an Antibody Purification Process

IMPROVED HCP REDUCTION USING A NEW, ALL‐SYNTHETIC DEPTH FILTRATION MEDIA WITHIN AN ANTIBODY PURIFICATION PROCESS

Within a typical CHO‐derived monoclonal antibody manufacturing process, a new, all‐synthetic depth filtration media is evaluated for...

PREVENTING FLU WITH AN ANTIBODY-PLUS-TAMIFLU UNIVERSAL VACCINE

The flu virus' ability to rapidly mutate into vaccine-resistant strains has made the search for a universal vaccine all the more challenging....

 
 
 

CELLULAR STRESS AT THE MOVIES

For the first time, biological imaging experts have used a custom fluorescence microscope and a novel antibody tagging tool to watch...

ANTI-FLU ANTIBODIES CAN INHIBIT TWO DIFFERENT VIRAL PROTEINS

Researchers have discovered that antibodies that may form the basis of a universal flu vaccine inhibit a second viral protein in addition...

 
 
 

GENSCRIPT LAUNCHES NOVEL TECHNOLOGY LICENSED FROM AMGEN FOR ACCELERATING PROTEIN AND ANTIBODY PURIFICATION

AmMag SA magnetic purification system first to offer high throughput of large samples, accelerating early stage drug development SAN...

Scientists believe llama antibodies may be the key ingredient for a universal flu vaccine

SCIENTISTS BELIEVE LLAMA ANTIBODIES MAY BE THE KEY INGREDIENT FOR A UNIVERSAL FLU VACCINE

A simple nasal spray using antibodies produced by llamas could give humans full protection from the flu. Scientists may have found...

 
 
 

ANTI-ICAM-1 ANTIBODY-MODIFIED NANOSTRUCTURED LIPID CARRIERS: A PULMONARY VASCULAR ENDOTHELIUM-TARGETED DEVICE FOR ACUTE LUNG INJURY THERAPY

Acute lung injury is a life-threatening clinical syndrome without effective treatment. Targeting delivery of glucocorticoid to lung...

UTILIZING A REGULATED TARGETED INTEGRATION CELL LINE DEVELOPMENT APPROACH TO SYSTEMATICALLY INVESTIGATE WHAT MAKES AN ANTIBODY DIFFICULT TO EXPRESS

Chinese hamster ovary cells are conventionally used to generate therapeutic cell lines via random integration , where desired transgenes...

 
 
 
Gilead Sciences Commits $150M to Agenus in Cancer Drug R&D Pact

GILEAD SCIENCES COMMITS $150M TO AGENUS IN CANCER DRUG R&D PACT

For the second time this week, Gilead Sciences has partnered with a Boston-area biotech, this time with a deal that covers up to five...

NOVO BAGS €430M STATEN BUYOUT OPTION TO BOOST CARDIOVASCULAR DISEASE PIPELINE

Novo Nordisk has landed an option to buy Staten Biotechnology in a €430 million deal. The agreement gives Novo the chance to add an...

 
 
 

NEWS OF NOTE-REDUCING THE RISKS OF BONE MARROW TRANSPLANT; AN ANTISENSE APPROACH TO EPILEPSY

The past week's biotech news included antibody-drug conjugates from Magenta to prevent toxic side effects of bone marrow transplants;...

SR. RESEARCH SCIENTIST/SCIENTIST/ASSOCIATE SCIENTIST

We are seeking an energetic, highly motivated, and creative scientist (Senior Scientist / Scientist/ Associate Scientist) with extensive...

 
 
 

DEVELOPMENT OF LUCIFERASE-LINKED ANTIBODY CAPTURE ASSAY BASED ON LUCIFERASE IMMUNOPRECIPITATION SYSTEMS FOR ANTIBODY DETECTION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS

Early detection of porcine reproductive and respiratory syndrome virus infection of swine is necessary to control this devastating...

GLAXOSMITHKLINE'S RHEUMATOID ARTHRITIS PROSPECT MISSES PHASE 2 ENDPOINT

GlaxoSmithKline has missed the primary endpoint in a phase 2 trial of rheumatoid arthritis prospect GSK3196165. The highest dose of...

 
 
 
3 win chemistry Nobel; findings led to best-selling drug

3 WIN CHEMISTRY NOBEL; FINDINGS LED TO BEST-SELLING DRUG

STOCKHOLM - Three researchers who "harnessed the power of evolution" to produce enzymes and antibodies that have led to a new best-selling...

A NEW WAY TO MANUFACTURE SMALL BATCHES OF BIOPHARMACEUTICALS ON DEMAND

Biopharmaceuticals, a class of drugs comprising proteins such as antibodies and hormones, represent a fast-growing sector of the pharmaceutical...

 
 
 

DATABASE ASSISTANT - PLANNING GROUP - BIOLEGEND - SAN DIEGO, CA

Previous experience in life science, biotechnology industry or process manufacturing industry. BioLegend develops world-class, cutting-edge...

BIOCEPT AWARDED PATENT IN HONG KONG FOR ITS TARGET SELECTOR PLATFORM USING ANTIBODIES AND A MICROCHANNEL TO PERFORM LIQUID BIOPSY

Expands the Company's global patent estate for the capture and detection of rare cells of interest, including CTCs shed by solid tumors,...